Code
MOG-NRAR-01CX
Test
Active-Compendium
81311
Clinical
Oncology,Pathology
Peripheral blood: 5 mL in EDTA tube.
Bone marrow: 2 mL in EDTA tube.
FFPE solid tumor tissue: Paraffin block is preferred. Alternatively, send 1 H&E slide plus 5-10 unstained slides cut at 5 or more microns. Please use positively-charged slides and 10% NBF fixative. Do not use zinc fixatives.
Note: Test is DNA-based. Please select Extract & Hold - DNA if specimen hold service is desired.
Bone marrow: 2 mL in EDTA tube.
FFPE solid tumor tissue: Paraffin block is preferred. Alternatively, send 1 H&E slide plus 5-10 unstained slides cut at 5 or more microns. Please use positively-charged slides and 10% NBF fixative. Do not use zinc fixatives.
Note: Test is DNA-based. Please select Extract & Hold - DNA if specimen hold service is desired.
Flag Active
True
Orderable Test Description
<p>The NRAS Mutation Analysis Assay is a real-time PCR-based assay designed to detect somatic mutations in exons 2, 3 and 4 of the NRAS gene. A "Detected" result indicates the presence of any of the following NRAS mutations: G12D/C/S, G13R/V, K117R, Q61H/L/K/R, A146T and A59D/T. Testing is available separately or in combination with BRAF, HRAS and KRAS in the NGS based RAS/RAF Panel.</p>
Orderable Turn Around Time
7 Days
Keywords
Orderable Biomarkers
NY Approved
True
Orderable Biomarkers JSON
{"DNA Sequencing": {"SNVs + Indels": ["NRAS"]}}
Keywords string
NRAS, NRAS Exon 2, NRAS Exon 3, RAS mutations, RAS/RAF Panel, NY, New York, codon 117, codon 146, exon 4 NRAS Mutation Analysis by PCR
Title URL
nras-mutation-analysis-by-pcr
Storage and transportation
Use cold pack for transport, making sure cold pack is not in direct contact with specimen. NYS clients please provide date and time of Collection.